Biotech Startups

GenePath Diagnostics is a molecular diagnostics company offering laboratory tests and assays for infectious diseases, cancers, and genetic disorders to medical professionals and patients. Established in India, the company provides rapid and sensitive molecular testing solutions positioned as more accessible and affordable than conventional diagnostic methods.

2 investors

Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.

2 investors

Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.

2 investors

GenFleet is a biopharmaceutical company developing novel drug therapies focused on RAS targeting and antibody-drug conjugates (ADCs) to address unmet clinical needs in cancer and other serious diseases.

2 investors

Genkore develops ultra-compact gene-editing technology to create therapeutic treatments for neurodegenerative diseases such as Huntington's and ALS. The company's gene scissors technology offers advantages in gene editing efficiency and delivery compared to existing approaches.

2 investors

Genobank provides a platform for patients to own, control, and monetize their genomic data through blockchain-linked biosamples and AI-powered bioinformatics workflows. The platform enables patients to share their biological data with researchers and clinical trials while maintaining transparency and earning potential from data licensing.

2 investors

Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases. The company partners with hospitals, health systems, and life sciences organizations to deliver expert genetic services at scale.

2 investors

GenomOncology builds precision oncology software, including its Precision Oncology Platform (POP) and a Pathology Workbench, along with content and curation data products for clinical genomics. It serves clinicians and researchers in cancer care through healthcare IT and bioinformatics tools.

2 investors

2 investors

GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases. The company is pursuing regulatory approval and early access programs in Europe.

2 investors

Genuine Taste develops ingredients and processes to lower the cost and improve the scalability of industrial cell culture, serving biomanufacturing across pharma, food, and chemicals. Originally a cell-agriculture company working on cultivated fat, it now provides the inputs and approaches used wherever cells are grown at scale.

2 investors

GenVault operates a GxP-compliant biorepository providing secure, temperature-controlled storage, sample management, and lab relocation services for biological, clinical, and biopharmaceutical materials. It serves pharma, biotech, academia, CROs, CDMOs, and government clients, offering ambient/CRT, cold room, freezer/ULT, and cryogenic storage backed by ISO, CAP, and FDA certifications.

2 investors

A pharmaceutical company whose executive team emphasizes innovation and patient care.

2 investors

Ghoonuts conducts research and development using transcranial electrical stimulation technology. The company appears to focus on neuroscience applications, with involvement in clinical neurophysiology and VR domains.

2 investors

GigaCrop develops engineered crops with improved photosynthesis to increase agricultural yields for food, fiber, and fuel production. The company uses synthetic biology and enzyme engineering to enhance plant productivity sustainably.

2 investors

Gisens Biotech develops G-LoC, a portable graphene-based biochip technology that delivers rapid health monitoring and diagnostic test results from home samples in minutes rather than days. The company's initial product, KF4+, is designed for patients with chronic kidney disease to perform comprehensive kidney function testing at home with results integrated into electronic health records.

2 investors

Glaukos develops micro-scale medical devices and pharmaceuticals for treating glaucoma, corneal disorders, and retinal diseases, replacing traditional drop therapies with minimally invasive surgery platforms. Founded in 1998 and publicly traded on the NYSE, the company serves ophthalmology patients globally.

2 investors

Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.

2 investors

Global Brains is a Japanese venture capital firm that invests across seed to late-stage startups, with particular focus on deep tech sectors including AI, climate tech, and healthcare alongside enterprise and commerce businesses.

2 investors

14.ai builds software that automates the core operations of e-commerce brands, handling customer acquisition, order fulfillment, and support with minimal human intervention, and uses the platform to operate its own direct-to-consumer business.

2 investors

GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.

2 investors

GlycoX develops a food ingredient derived from a native plant oil that aims to reduce post-meal blood-sugar spikes and support metabolic health. It is positioned as a preventive, food-based approach to glucose control and longevity for everyday consumers.

2 investors

GOOD Meat produces cultivated chicken meat made from animal cells without animal slaughter, approved for sale in Singapore and the United States and available at select restaurants. The company is a brand of Eat Just, Inc., which also produces plant-based egg products.

2 investors

Grand River Aseptic Manufacturing (GRAM) is a contract development and manufacturing organization (CDMO) specializing in sterile fill-finish and aseptic manufacturing of injectable pharmaceutical and biologic products. It serves pharmaceutical and biotech clients across the drug product lifecycle, from development through commercial supply.

2 investors